Oxford BioDynamics Plc (LON:OBD – Get Free Report)’s stock price was up 9% during trading on Wednesday . The company traded as high as GBX 1.20 ($0.02) and last traded at GBX 1.03 ($0.01). Approximately 1,819,385 shares changed hands during trading, a decline of 3% from the average daily volume of 1,876,246 shares. The stock had previously closed at GBX 0.94 ($0.01).
Oxford BioDynamics Price Performance
The company has a 50-day moving average of GBX 1.46 and a 200 day moving average of GBX 4.69. The company has a debt-to-equity ratio of 370.22, a quick ratio of 2.80 and a current ratio of 0.68. The firm has a market cap of £3.43 million, a P/E ratio of -16.30 and a beta of 0.42.
Insider Activity
In related news, insider David Holbrook purchased 49,653 shares of the stock in a transaction dated Monday, October 28th. The stock was bought at an average cost of GBX 1 ($0.01) per share, with a total value of £496.53 ($631.24). 16.78% of the stock is currently owned by corporate insiders.
Oxford BioDynamics Company Profile
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.
Featured Stories
- Five stocks we like better than Oxford BioDynamics
- What is a Low P/E Ratio and What Does it Tell Investors?
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- Best Stocks Under $5.00
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- CD Calculator: Certificate of Deposit Calculator
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
